🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lipe & Dalton - Q4 2025 13F Filings

LI

Lipe & Dalton

CIK: 0001570396
Address: New York Syracuse 103 East Water Street Suite 305
$202.43 M
Portfolio Value
95
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 10/14/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025

Top Sells

Q4 2025
−$904,000
−$804,565.18
−$674,740.78
−$351,503.48

Asset Allocation

Stocks/ETFs
+0.48%
$199.14 M 98.37%
Options
$0 0.00%
Debt
$0 0.00%
Other
-10.16%
$3.3 M 1.63%

Sector Allocation (Stocks)

Lipe & Dalton Q4 2025 Filing Summary

Lipe & Dalton filed its 13F report for Q4 2025 on January 26, 2026. The portfolio totaled 202.43 M reflecting a +0.29% change from the prior quarter, spanning 95 assets. The top 10 holdings comprised 46.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 4 new positions and 2 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Lipe & Dalton’s Q4 2025 Filing

Lipe & Dalton submitted their Form 13F-HR for the Q4 2025 period on 01/26/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Lipe & Dalton reported a managed portfolio value of 202.43 M, consisting of 95 individual positions.

This page displays the raw filing documents. To see which stocks Lipe & Dalton bought or sold during Q4 2025, please visit Lipe & Dalton's Portfolio Analysis page.